MERRIMACK PHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding from Q1 2012 to Q1 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Merrimack Pharmaceuticals Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2012 to Q1 2024.
  • Merrimack Pharmaceuticals Inc Entity Common Stock, Shares Outstanding for the quarter ending March 15, 2024 was 14.5M shares, a 1.94% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 14.5M +277K +1.94% Mar 15, 2024 10-K/A 2024-03-21
Q3 2023 14.3M +911K +6.79% Oct 31, 2023 10-Q 2023-11-02
Q2 2023 14.3M +911K +6.79% Aug 1, 2023 10-Q 2023-08-03
Q1 2023 14.3M +845K +6.3% Mar 7, 2023 10-K 2023-03-09
Q3 2022 13.4M 0 0% Nov 1, 2022 10-Q 2022-11-03
Q2 2022 13.4M 0 0% Aug 2, 2022 10-Q 2022-08-04
Q1 2022 13.4M 0 0% Mar 7, 2022 10-K 2022-03-09
Q3 2021 13.4M +30K +0.22% Nov 2, 2021 10-Q 2021-11-04
Q2 2021 13.4M +30K +0.22% Aug 2, 2021 10-Q 2021-08-05
Q1 2021 13.4M +30K +0.22% Mar 8, 2021 10-K 2021-03-10
Q3 2020 13.4M +17.3K +0.13% Nov 2, 2020 10-Q 2020-11-04
Q2 2020 13.4M +30.4K +0.23% Aug 3, 2020 10-Q 2020-08-07
Q1 2020 13.4M +37.5K +0.28% Mar 8, 2020 10-K 2020-03-12
Q3 2019 13.4M +20.2K +0.15% Nov 8, 2019 10-Q 2019-11-12
Q2 2019 13.3M +7.04K +0.05% Jul 10, 2019 10-Q 2019-07-17
Q1 2019 13.3M 0 0% Feb 27, 2019 10-K 2019-03-06
Q3 2018 13.3M +9.82K +0.07% Nov 1, 2018 10-Q 2018-11-07
Q2 2018 13.3M -119M -90% Aug 2, 2018 10-Q 2018-08-07
Q1 2018 13.3M -119M -89.9% Mar 7, 2018 10-K 2018-03-12
Q3 2017 13.3M -116M -89.7% Nov 7, 2017 10-Q 2017-11-08
Q2 2017 133M +3.55M +2.75% Aug 8, 2017 10-Q 2017-08-09
Q1 2017 132M +4.7M +3.68% May 9, 2017 10-Q 2017-05-10
Q3 2016 130M +14M +12.2% Nov 4, 2016 10-Q 2016-11-09
Q2 2016 129M +17.8M +16% Jul 29, 2016 10-Q 2016-08-04
Q1 2016 128M +17.7M +16.1% Apr 27, 2016 10-Q 2016-05-02
Q3 2015 116M +9.69M +9.15% Oct 31, 2015 10-Q 2015-11-09
Q2 2015 111M +6.83M +6.53% Jul 31, 2015 10-Q 2015-08-10
Q1 2015 110M +6.62M +6.4% Apr 30, 2015 10-Q 2015-05-07
Q4 2014 107M Feb 13, 2015 10-K 2015-02-27
Q3 2014 106M +3.54M +3.46% Oct 31, 2014 10-Q 2014-11-10
Q2 2014 105M +2.38M +2.33% Jul 31, 2014 10-Q 2014-08-11
Q1 2014 103M +7.32M +7.62% Apr 30, 2014 10-Q 2014-05-06
Q3 2013 102M +8.17M +8.67% Oct 31, 2013 10-Q 2013-11-08
Q2 2013 102M +8.49M +9.06% Jul 31, 2013 10-Q 2013-08-08
Q1 2013 96.1M +2.79M +2.99% Apr 30, 2013 10-Q 2013-05-13
Q3 2012 94.2M Oct 31, 2012 10-Q 2012-11-14
Q2 2012 93.7M Jul 31, 2012 10-Q 2012-08-14
Q1 2012 93.3M Apr 30, 2012 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.